Synopsis
Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Blastocarb
2. Carboplat
3. Carboplatin
4. Carbosin
5. Carbotec
6. Cbdca
7. Cis-diammine(cyclobutanedicarboxylato)platinum Ii
8. Ercar
9. Jm 8
10. Jm-8
11. Jm8
12. Nealorin
13. Neocarbo
14. Nsc 241240
15. Nsc-241240
16. Nsc241240
17. Paraplatin
18. Paraplatine
19. Platinwas
20. Ribocarbo
1. Paraplatin
2. Cbdca
3. Jm-8
4. Cis-diammine(1,1-cyclobutanedicarboxylato)platinum
5. Nsc 241240
6. Nsc-241240
7. Carboplatin [usan]
8. Bg3f62ond5
9. Cis-diammine(1,1-cyclobutanedicarboxylato) Platinum
10. Platinum, Diammine [1,1-cyclobutane-dicarboxylato(2-)-0,0']-,(sp-4-2)
11. Nsc-201345
12. Carboplatin [mi]
13. Carboplatin [inn]
14. Carboplatin [jan]
15. Carboplatin [hsdb]
16. Carboplatin [vandf]
17. Carboplatin [mart.]
18. Carboplatin [usp-rs]
19. Carboplatin [who-dd]
20. Cis-diamine(1,1-cyclobutanedicarboxylato)platinum(ii)
21. Carboplatin [ep Impurity]
22. Carboplatin [orange Book]
23. Carboplatin [ep Monograph]
24. Carboplatin [usp Impurity]
25. Carboplatin [usp Monograph]
26. Amy33401
27. S1215
28. Akos037515487
29. Ccg-268304
30. Ab01568249_01
31. Q415588
32. W-106301
33. Platinum, Diamine(1,1-cyclobutanedicarboxylato (2-)-o,o')-, (sp-4-2)-
Molecular Weight | 371.25 g/mol |
---|---|
Molecular Formula | C6H12N2O4Pt |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 0 |
Exact Mass | 371.044501 g/mol |
Monoisotopic Mass | 371.044501 g/mol |
Topological Polar Surface Area | 82.3 Ų |
Heavy Atom Count | 13 |
Formal Charge | 0 |
Complexity | 153 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 4 |
1 of 2 | |
---|---|
Drug Name | Carboplatin |
PubMed Health | Carboplatin (Injection) |
Drug Classes | Antineoplastic Agent |
Drug Label | Carboplatin injection is supplied as a sterile, pyrogen-free, 10 mg/mL aqueous solution of carboplatin. Carboplatin is a platinum coordination compound. The chemical name for carboplatin is platinum, diammine [1,1-cyclobutane-dicarboxylato(2-)-0,0... |
Active Ingredient | Carboplatin |
Dosage Form | Injectable |
Route | Iv (infusion) |
Strength | 450mg/45ml (10mg/ml); 150mg/15ml (10mg/ml); 600mg/60ml (10mg/ml); 1gm/100ml (10mg/ml); 50mg/5ml (10mg/ml) |
Market Status | Prescription |
Company | Pliva Lachema; Actavis Elizabeth; Fresenius Kabi Usa; Hospira; Mylan Institutional; Fresenius Kabi Oncol; Ebewe Pharma; Pharmachemie Bv; Onco Therapies; Teva Pharms Usa; Eurohlth Intl; Sagent Pharms; Cipla; Sun Pharma Global; Akorn |
2 of 2 | |
---|---|
Drug Name | Carboplatin |
PubMed Health | Carboplatin (Injection) |
Drug Classes | Antineoplastic Agent |
Drug Label | Carboplatin injection is supplied as a sterile, pyrogen-free, 10 mg/mL aqueous solution of carboplatin. Carboplatin is a platinum coordination compound. The chemical name for carboplatin is platinum, diammine [1,1-cyclobutane-dicarboxylato(2-)-0,0... |
Active Ingredient | Carboplatin |
Dosage Form | Injectable |
Route | Iv (infusion) |
Strength | 450mg/45ml (10mg/ml); 150mg/15ml (10mg/ml); 600mg/60ml (10mg/ml); 1gm/100ml (10mg/ml); 50mg/5ml (10mg/ml) |
Market Status | Prescription |
Company | Pliva Lachema; Actavis Elizabeth; Fresenius Kabi Usa; Hospira; Mylan Institutional; Fresenius Kabi Oncol; Ebewe Pharma; Pharmachemie Bv; Onco Therapies; Teva Pharms Usa; Eurohlth Intl; Sagent Pharms; Cipla; Sun Pharma Global; Akorn |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
Cross-Linking Reagents
Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. (See all compounds classified as Cross-Linking Reagents.)
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-02-13
Pay. Date : 2015-02-02
DMF Number : 7145
Submission : 1987-09-17
Status : Active
Type : II
Certificate Number : R1-CEP 2004-104 - Rev 03
Issue Date : 2023-03-27
Type : Chemical
Substance Number : 1081
Status : Valid
Registration Number : 222MF10101
Registrant's Address : 435 Devon Park Drive, Suite 400, Wayne, Pennsylvania 19087 USA
Initial Date of Registration : 2010-03-18
Latest Date of Registration : --
NDC Package Code : 49812-0010
Start Marketing Date : 2014-01-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
GDUFA
DMF Review : Reviewed
Rev. Date : 2012-12-24
Pay. Date : 2012-12-03
DMF Number : 17659
Submission : 2004-09-08
Status : Active
Type : II
Certificate Number : R1-CEP 2000-375 - Rev 04
Issue Date : 2022-04-13
Type : Chemical
Substance Number : 1081
Status : Valid
Available Reg Filing : ASMF |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15938
Submission : 2002-04-18
Status : Active
Type : II
Certificate Number : R1-CEP 2002-129 - Rev 01
Issue Date : 2008-09-16
Type : Chemical
Substance Number : 1081
Status : Valid
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-09-23
Pay. Date : 2014-03-06
DMF Number : 28047
Submission : 2014-03-10
Status : Active
Type : II
Certificate Number : R1-CEP 2009-264 - Rev 03
Issue Date : 2019-10-24
Type : Chemical
Substance Number : 1081
Status : Valid
Registration Number : 226MF10121
Registrant's Address : Calle 14, Nr. 229 (Lote 13), B1629MXA, Parque Industrial Pilar, Buenos Aires, Argentina
Initial Date of Registration : 2014-06-18
Latest Date of Registration : --
NDC Package Code : 72659-863
Start Marketing Date : 2017-01-02
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29100
Submission : 2015-02-10
Status : Active
Type : II
Certificate Number : CEP 2009-383 - Rev 04
Issue Date : 2024-06-26
Type : Chemical
Substance Number : 1081
Status : Valid
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-03-28
Pay. Date : 2023-09-27
DMF Number : 24201
Submission : 2010-09-25
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16664
Submission : 2003-06-20
Status : Active
Type : II
Certificate Number : CEP 2003-155 - Rev 03
Issue Date : 2023-12-14
Type : Chemical
Substance Number : 1081
Status : Valid
Date of Issue : 2022-06-08
Valid Till : 2025-07-25
Written Confirmation Number : WC-0159
Address of the Firm :
GDUFA
DMF Review : Complete
Rev. Date : 2015-02-13
Pay. Date : 2015-02-02
DMF Number : 7145
Submission : 1987-09-17
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2012-12-24
Pay. Date : 2012-12-03
DMF Number : 17659
Submission : 2004-09-08
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16916
Submission : 2003-10-21
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-09-28
Pay. Date : 2013-09-20
DMF Number : 15147
Submission : 2000-11-17
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16709
Submission : 2003-07-15
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-04-17
Pay. Date : 2013-04-08
DMF Number : 21918
Submission : 2008-08-29
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16280
Submission : 2002-12-02
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15938
Submission : 2002-04-18
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16664
Submission : 2003-06-20
Status : Active
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9541
Submission : 1992-01-03
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?